New pro-oxidant supplement shows promise in slowing prostate cancer progression

Prostate cancer is a quiet killer. In most men, it’s treatable. However, in some cases, it resists all known therapies and turns extremely deadly.

GSK seeks to extend RSV vaccine use in adults aged 50-59 years

Share this article GSK’s RSV vaccine could soon be available for adults aged 50-59 at risk of RSV disease. Credit: GSK plc. The European Medicines

January 30, 2024

SPY ETF will fall with interest rates heading higher, and here is my take on SPY ETF

May 31, 2023

Sosei wins South Korean approval for brain injury drug – Pharmaceutical Technology

Share this article Sosei’s brain injury drug gained a marketing approval in South Korea. Credit: Prostock-Studio via Getty Images. The Sosei Group (Sosei Heptares) announced

December 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.